Filing Details

Accession Number:
0001209191-23-016362
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-06 16:59:26
Reporting Period:
2023-03-02
Accepted Time:
2023-03-06 16:59:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834161 Mark Eisner C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-02 1,187 $21.87 172,496 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.